CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Isu Abxis Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Isu Abxis Co Ltd
5F, C Dong, Global R&D Center,
22, Daewangpangyoro 712-Gil, Bundang-Gu
Phone: +82 316964700p:+82 316964700 SEONGNAM, 13488  South Korea Ticker: 086890086890

Business Summary
ISU Abxis Co., Ltd. is a Korea-based company mainly engaged in the biopharmaceutical business. The Company operates its business under two divisions: antibody therapeutics business division and diagnostic business division. Its antibody therapeutics business division engages in the development of Cloticab, which is a monoclonal therapeutic antibody for thrombus. Its diagnostic business division engages in the provision of genetic testing services and chemotherapy response assay services for cancer examination.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer, Director YeopHwang 57 3/25/2022 12/31/2021
Internal Auditor Seong HunLee 54
Non-Executive Independent Director Gyun MinLee 54 3/23/2012 3/23/2012

Business Names
Business Name
086890
A086890
ISU abxis Co., Ltd.

General Information
Number of Employees: 166 (As of 12/31/2023)
Outstanding Shares: 34,611,239 (As of 12/31/2023)
Shareholders: 29,407
Stock Exchange: KDQ
Fax Number: +82 316964691


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024